Hyunjoon Kim, PhD

Assistant Professor
University of Kansas

Hyunjoon Kim Kim research group at University of Kansas, Department of Pharmaceutical Chemistry, works on development of engineered biomaterials for drug delivery and immunotherapy. Our ultimate goal is to invent translational medicine that can make a positive impact in the clinic. Current research projects includes bladder cancer immunotherapy and autoimmune disease therapies.

Poster(s):

• (W0930-05-27) Decellularization of Porcine Bladder as a Biocompatible Platform for Evaluating In Vitro Drug Efficacy
  Wednesday, November 12, 2025

  9:30 AM - 10:30 AM CT

• (T0930-06-36) Development of Injectable Chitosan-Based Hydrogels for Sustained Bladder Delivery of Therapeutic Proteins
  Tuesday, November 11, 2025

  9:30 AM - 10:30 AM CT

• (M1030-07-41) Elucidating Immunomodulatory Mechanism of Bifunctional Peptide Inhibitors Using Mouse Model of EAE
  Monday, November 10, 2025

  10:30 AM - 11:30 AM CT

• (T1230-06-35) Lectin Conjugated Liposome Nanocarriers for Targeted Bladder Cancer Therapy
  Tuesday, November 11, 2025

  12:30 PM - 1:30 PM CT

• (T1430-03-16) Evaluation of a Toll-Like Receptor 7/8 Antagonist for Anti-Inflammatory Immunotherapy
  Tuesday, November 11, 2025

  2:30 PM - 3:30 PM CT

• (T1530-06-36) Oral Delivery of Anti-TNF-α Antibody via Pickering Emulsion for Ulcerative Colitis Therapy
  Tuesday, November 11, 2025

  3:30 PM - 4:30 PM CT